GlobeNewswire

ASHBURN, Va., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Telos Corporation (NASDAQ: TLS), a leading provider of cyber, cloud and enterprise security solutions for the world’s most security-conscious organizations, today announced that it will report third quarter 2025 financial results on Monday, November 10, 2025. Management will host a webcast to discuss the Company’s financial results and business outlook at 9:30 a.m. ET. What:Telos Corporation Third Quarter 2025 Financial Results ...

Primary Logo

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Oct. 27, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, presented posters at the 2025 EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics highlighting preclinical data that further illustrate the potential for ORIC-944, a potent and selective allosteric inhibitor of the ...

Primary Logo

NEWPORT BEACH, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Amaze Holdings, Inc. (NYSE American: AMZE) (“Amaze”), a global leader in creator-powered commerce, today announced Amaze Moments, an advanced AI engine designed to help creators and brands identify and act on spikes in traffic, fan engagement, and cultural relevance — empowering them to capitalize on those moments in real time and maximize revenue when attention is at its peak. Every day, millions of creator moments ignite ...

Primary Logo

MIDDLETON, Wis. and SARASOTA, Fla., Oct. 27, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare fertility company focused on expanding access to advanced treatment through the establishment, acquisition and operation of fertility clinics and related businesses and technologies, today announced a strategic partnership with Heidi Health to integrate its innovative AI-powered scribe platform at INVO’s Wisconsin Fertility ...

Primary Logo

The unbeatable combination of America’s Patriotic Brand and cutting-edge digital intelligence through our investment in RAEK is designed to achieve a singular goal: accelerating data-driven growth and deepening customer loyalty. This strategic move is designed to enhance American Rebel's future success and increase shareholder value Nashville, TN, Oct. 27, 2025 (GLOBE NEWSWIRE) -- American Rebel Holdings, Inc. (NASDAQ: AREB) — America’s Patriotic Brand — today highlighted the ...

Primary Logo

HONG KONG, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Waton Financial Limited (NASDAQ: WTF), a provider of securities brokerage and financial technology services (“Waton” or the “Company”), today announced the launch of its revamped corporate website. The revamped website is aimed at showcasing Waton’s strategic evolution from a traditional securities brokerage firm into a financial and crypto digital asset enterprise committed to artificial intelligence investment and financial technology ...

Primary Logo

Richland, WA, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) announced today that they have appointed Dr. John J. Smith, M.D., J.D., and his team at Hogan Lovells as the company’s lead regulatory advisors for its FDA Investigational Device Exemption (IDE) submission for RadioGel®. Dr. Smith, a board-certified diagnostic radiologist and former associate professor at Harvard Medical School, is widely recognized as one of the nation’s leading FDA regulatory consultants in ...

Primary Logo

NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Bakkt Holdings, Inc. (“Bakkt” or the “Company”) (NYSE:BKKT) announced today that it will release its third quarter 2025 earnings on Monday, November 10, 2025, before market open. Management will host a conference call at 8:30 AM EST on the same day to review the results and answer questions. The conference call will be webcast live and archived on the investor relations section of Bakkt’s corporate website under the ‘News & Events’ ...

SINGAPORE, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Multi Ways Holdings Limited (“Multi Ways,” the “Company” or the “Issuer”) (NYSE American: MWG), a leading supplier of a wide range of heavy construction equipment for sales and rental in Singapore and the surrounding region, is pleased to announce it has placed additional new orders for 21 Sany cranes for approximately S$7.0 million (US$5.4 million). The majority of these orders are already confirmed with customers in Singapore. This ...

Primary Logo

Financing designed to support Phase 2 Parkinson’s trial and accelerate Nugevia™ product line growth Jupiter, FL, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc (“JUNS” or the “Company”) (NASDAQ: JUNS), a clinical stage biopharmaceutical company that is advancing a therapeutic pipeline targeting central nervous system (“CNS”) disorders, while also expanding into the consumer longevity market with its Nugevia™ product line, today announced that it has entered into two ...

Primary Logo

BETHLEHEM, Pa., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Embassy Bancorp, Inc. (OTCQX: EMYB) (the “Company”), the parent company of Embassy Bank For the Lehigh Valley (the “Bank”), announces that the Board of Directors has authorized the adoption of a stock repurchase program for up to $5 million of its outstanding common stock. The stock repurchase program will become effective October 31, 2025. This is Embassy Bancorp, Inc.’s first stock repurchase program. Repurchases under this ...

Primary Logo

VANCOUVER, British Columbia, Oct. 27, 2025 (GLOBE NEWSWIRE) -- via IBN -- Branded Legacy, Inc. (OTC:BLEG), a leader in innovative addiction treatment and harm reduction solutions, today announced that its subsidiary, BioLegacy Evaluative Group Inc., has initiated engineering and development of a unitary device mold for its proprietary air-driven intranasal drug delivery platform. This milestone marks a significant step toward scalable production of its groundbreaking single-use ...

Primary Logo

FLORHAM PARK, N.J., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced the U.S. Food and Drug Administration (FDA) has granted rare pediatric drug designation (RPDD) for iopofosine I 131 in inoperable relapsed or refractory pediatric high-grade glioma (r/r pHGG). Iopofosine I 131 is a potential first-in-class, ...

Primary Logo

NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced the immediate exercise of warrants, previously issued in March and August 2024 (the “Existing Warrants”), to purchase up to 22,363,714 shares of its common stock for gross cash proceeds of approximately $31.0 ...

Primary Logo

Powered by SPD-SmartGlass Film invented by Research Frontiers and Produced by Gauzy, this First-of-its-Kind Retrofit Dimmable Glazing System Transforms Building Facades Orlando, FL, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR), the inventor and licensor of patented SPD-Smart film light-control technology, and Advanced Impact Technologies Group (AIT Group), a fully-integrated premier manufacturer of advanced functional glass solutions, and licensee of ...

Primary Logo

TAMPA, Fla., Oct. 27, 2025 (GLOBE NEWSWIRE) -- HCI Group, Inc. (NYSE: HCI) will hold a conference call on Thursday, November 6, 2025, at 4:45 p.m. Eastern Time to discuss results for the third quarter ended September 30, 2025. Financial results will be issued in a press release the same day after the close of the market. HCI management will host the presentation, followed by a question-and-answer period. Interested parties can listen to the live presentation by dialing the ...

Primary Logo

MOUNTAIN VIEW, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a novel, FDA-cleared drug-delivery device, today announced that it will host its third quarter 2025 financial results and business highlights conference call on November 13, 2025, at 4:30 p.m. ET. Additional details will be available on the Investor Relations ...

Primary Logo

EAU CLAIRE, Wis., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Citizens Community Bancorp, Inc. (the “Company”) (Nasdaq: CZWI), the parent company of Citizens Community Federal N.A. (the “Bank” or “CCFBank”), today reported earnings of $3.7 million and earnings per diluted share of $0.37 for the third quarter ended September 30, 2025, compared to $3.3 million and earnings per diluted share of $0.33 for the second quarter ended June 30, 2025, and $3.3 million and $0.32 earnings per diluted ...

Primary Logo

Strategic improvements to proprietary fraud prevention system drive customer acquisition growth while maintaining platform security SCHAUMBURG, IL, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Giftify, Inc. (NASDAQ: GIFT) (the "Company"), the owner and operator of CardCash.com, Restaurant.com, and Takeout7.com, and a leader in the incentives and rewards industry, today announced that CardCash.com, its leading platform for buying and selling gift cards, has achieved an over 10% increase in the ...

Primary Logo

NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Huntington Bancshares Incorporated (NASDAQ: HBAN) and Cadence Bank is fair to Huntington shareholders. Halper Sadeh encourages Huntington shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns ...

Primary Logo